ArticleCrohn's & colitis 3602025

Development and Validation of a Scoring System to Predict 2-Year Clinical Remission in Ulcerative Colitis Patients on Vedolizumab.

Thanaboon Chaemsupaphan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.